Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion.

Ziani L, Safta-Saadoun TB, Gourbeix J, Cavalcanti A, Robert C, Favre G, Chouaib S, Thiery J.

Oncotarget. 2017 Mar 21;8(12):19780-19794. doi: 10.18632/oncotarget.15540.

2.

Physiologically activated mammary fibroblasts promote postpartum mammary cancer.

Guo Q, Minnier J, Burchard J, Chiotti K, Spellman P, Schedin P.

JCI Insight. 2017 Mar 23;2(6):e89206. doi: 10.1172/jci.insight.89206.

3.

Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells.

Ubellacker JM, Haider MT, DeCristo MJ, Allocca G, Brown NJ, Silver DP, Holen I, McAllister SS.

Breast Cancer Res. 2017 Mar 6;19(1):23. doi: 10.1186/s13058-017-0815-8.

4.

Macrophages as Key Drivers of Cancer Progression and Metastasis.

Nielsen SR, Schmid MC.

Mediators Inflamm. 2017;2017:9624760. doi: 10.1155/2017/9624760. Epub 2017 Jan 22. Review.

5.

Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway.

Tao L, Huang G, Wang R, Pan Y, He Z, Chu X, Song H, Chen L.

Sci Rep. 2016 Dec 6;6:38408. doi: 10.1038/srep38408.

6.

ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.

Magnusson K, Gremel G, Rydén L, Pontén V, Uhlén M, Dimberg A, Jirström K, Pontén F.

BMC Cancer. 2016 Nov 18;16(1):904.

7.

The unresolved role of systemic factors in bone metastasis.

Ubellacker JM, McAllister SS.

J Bone Oncol. 2016 May 16;5(3):96-99. eCollection 2016 Sep.

8.

Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers.

Allaoui R, Bergenfelz C, Mohlin S, Hagerling C, Salari K, Werb Z, Anderson RL, Ethier SP, Jirström K, Påhlman S, Bexell D, Tahin B, Johansson ME, Larsson C, Leandersson K.

Nat Commun. 2016 Oct 11;7:13050. doi: 10.1038/ncomms13050.

9.

Cancer stem cells: progress and challenges in lung cancer.

Templeton AK, Miyamoto S, Babu A, Munshi A, Ramesh R.

Stem Cell Investig. 2014 Apr 15;1:9. doi: 10.3978/j.issn.2306-9759.2014.03.06. eCollection 2014. Review.

10.

Translational aspects in targeting the stromal tumour microenvironment: from bench to bedside.

Bhome R, Al Saihati HA, Goh RW, Bullock MD, Primrose JN, Thomas GJ, Sayan AE, Mirnezami AH.

New Horiz Transl Med. 2016 Jan;3(1):9-21.

11.

Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis.

Nielsen SR, Quaranta V, Linford A, Emeagi P, Rainer C, Santos A, Ireland L, Sakai T, Sakai K, Kim YS, Engle D, Campbell F, Palmer D, Ko JH, Tuveson DA, Hirsch E, Mielgo A, Schmid MC.

Nat Cell Biol. 2016 May;18(5):549-60. doi: 10.1038/ncb3340. Epub 2016 Apr 18.

12.

Mechanical signals regulate and activate SNAIL1 protein to control the fibrogenic response of cancer-associated fibroblasts.

Zhang K, Grither WR, Van Hove S, Biswas H, Ponik SM, Eliceiri KW, Keely PJ, Longmore GD.

J Cell Sci. 2016 May 15;129(10):1989-2002. doi: 10.1242/jcs.180539. Epub 2016 Apr 12.

13.

Osteopontin-integrin interaction as a novel molecular target for antibody-mediated immunotherapy in adult T-cell leukemia.

Maeda N, Ohashi T, Chagan-Yasutan H, Hattori T, Takahashi Y, Harigae H, Hasegawa H, Yamada Y, Fujii M, Maenaka K, Uede T.

Retrovirology. 2015 Nov 24;12:99. doi: 10.1186/s12977-015-0225-x.

14.

The Role of the Transcriptional Regulation of Stromal Cells in Chronic Inflammation.

Valin A, Pablos JL.

Biomolecules. 2015 Oct 16;5(4):2723-57. doi: 10.3390/biom5042723. Review.

15.

S100A9 expressed in ER(-)PgR(-) breast cancers induces inflammatory cytokines and is associated with an impaired overall survival.

Bergenfelz C, Gaber A, Allaoui R, Mehmeti M, Jirström K, Leanderson T, Leandersson K.

Br J Cancer. 2015 Oct 20;113(8):1234-43. doi: 10.1038/bjc.2015.346. Epub 2015 Oct 8.

16.

Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer.

Mehmeti M, Allaoui R, Bergenfelz C, Saal LH, Ethier SP, Johansson ME, Jirström K, Leandersson K.

Breast Cancer Res. 2015 Sep 22;17:130. doi: 10.1186/s13058-015-0640-x.

17.

Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous niche.

Pantziarka P.

Ecancermedicalscience. 2015 May 21;9:541. doi: 10.3332/ecancer.2015.541. eCollection 2015.

18.

Gastrointestinal Fibroblasts Have Specialized, Diverse Transcriptional Phenotypes: A Comprehensive Gene Expression Analysis of Human Fibroblasts.

Higuchi Y, Kojima M, Ishii G, Aoyagi K, Sasaki H, Ochiai A.

PLoS One. 2015 Jun 5;10(6):e0129241. doi: 10.1371/journal.pone.0129241. eCollection 2015.

19.

Monocytes and macrophages, implications for breast cancer migration and stem cell-like activity and treatment.

Ward R, Sims AH, Lee A, Lo C, Wynne L, Yusuf H, Gregson H, Lisanti MP, Sotgia F, Landberg G, Lamb R.

Oncotarget. 2015 Jun 10;6(16):14687-99.

20.

Granulin, a novel STAT3-interacting protein, enhances STAT3 transcriptional function and correlates with poorer prognosis in breast cancer.

Yeh JE, Kreimer S, Walker SR, Emori MM, Krystal H, Richardson A, Ivanov AR, Frank DA.

Genes Cancer. 2015 Mar;6(3-4):153-68.

Supplemental Content

Support Center